Skin cancer is an abnormal growth of skin cells. At UT Southwestern Medical Center, our skin cancer program – like all our clinical programs – integrates current research discoveries to ensure that our patients receive the most accurate diagnoses and the most effective treatments available.
In fact, our clinical trials program gives patients access to treatments often unavailable at other health care facilities. Depending on the patient's specific condition and the type of skin cancer, UT Southwestern can offer patients therapies that show particular promise in treating their form of skin cancer years before they are offered to the public.
There are different kinds of skin cancer, but the three most common are basal cell carcinoma, squamous cell carcinoma, and melanoma:
Cutaneous T-cell lymphoma (CTCL) is a type of non-Hodgkin's lymphoma. CTCL first appears on the skin. In most patients, CTCL may be treated effectively by directing therapy against those skin manifestations. In cases in which the disease has advanced, our dermatology specialists work as team members with oncologists and other physicians.
UT Southwestern Medical Center offers some of the most advanced therapies available for the treatment of skin cancer. Our specialists are leading experts in the use of topical chemotherapy, electrosurgery, cryosurgery, laser surgery, conventional excisional surgery, and Mohs surgery. They also are widely respected by their peers as leaders in the treatment of skin cancer.
Our program conducts groundbreaking research into the causes and cures for all types of skin cancer. UT Southwestern is a major contributor to ongoing scientific investigation sponsored by the John Wayne Cancer Institute, which is exploring how innovative therapies can prevent or delay the recurrence of skin cancer in high-risk patients.
Individuals with a family history of skin cancer also can benefit from UT Southwestern’s specialists and state-of-the-art medical facilities to prevent the occurrence or recurrence of skin cancer.
UT Southwestern has three specialty clinical practices focused on the treatment of skin cancer: